Samantha Matson

1.2k total citations
14 papers, 942 citations indexed

About

Samantha Matson is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Samantha Matson has authored 14 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 4 papers in Neurology. Recurrent topics in Samantha Matson's work include Genetic Neurodegenerative Diseases (6 papers), Mitochondrial Function and Pathology (4 papers) and Tryptophan and brain disorders (3 papers). Samantha Matson is often cited by papers focused on Genetic Neurodegenerative Diseases (6 papers), Mitochondrial Function and Pathology (4 papers) and Tryptophan and brain disorders (3 papers). Samantha Matson collaborates with scholars based in United States, Singapore and Switzerland. Samantha Matson's co-authors include Wayne R. Matson, Robert J. Ferrante, Steven M. Hersch, Karen Smith, Hoon Ryu, Edward C. Stack, Kerry Cormier, Arthur J.L. Cooper, M. Flint Beal and Rajiv R. Ratan and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Neurology.

In The Last Decade

Samantha Matson

14 papers receiving 923 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samantha Matson United States 10 587 408 258 99 87 14 942
Phillip M. Rappold United States 11 463 0.8× 400 1.0× 322 1.2× 28 0.3× 79 0.9× 18 1.1k
Marie‐Claude Gaillard France 15 644 1.1× 488 1.2× 176 0.7× 52 0.5× 24 0.3× 21 1.0k
Eduard Bentea Belgium 17 276 0.5× 298 0.7× 176 0.7× 103 1.0× 41 0.5× 39 794
Julia C. Fitzgerald Germany 19 591 1.0× 216 0.5× 270 1.0× 53 0.5× 22 0.3× 30 1.0k
Frank Schuettauf Germany 20 890 1.5× 308 0.8× 87 0.3× 68 0.7× 19 0.2× 49 1.5k
Giulia Ambrosi Italy 17 347 0.6× 294 0.7× 324 1.3× 24 0.2× 28 0.3× 26 941
Frédéric Léveillé France 11 645 1.1× 564 1.4× 89 0.3× 66 0.7× 19 0.2× 13 1.2k
Rakel López de Maturana United Kingdom 19 612 1.0× 447 1.1× 221 0.9× 27 0.3× 20 0.2× 23 1.2k
Ludmila A. Voloboueva United States 13 573 1.0× 236 0.6× 92 0.4× 44 0.4× 33 0.4× 18 1.2k
Nina Vartiainen Finland 15 437 0.7× 400 1.0× 208 0.8× 38 0.4× 11 0.1× 16 1.0k

Countries citing papers authored by Samantha Matson

Since Specialization
Citations

This map shows the geographic impact of Samantha Matson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samantha Matson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samantha Matson more than expected).

Fields of papers citing papers by Samantha Matson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samantha Matson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samantha Matson. The network helps show where Samantha Matson may publish in the future.

Co-authorship network of co-authors of Samantha Matson

This figure shows the co-authorship network connecting the top 25 collaborators of Samantha Matson. A scholar is included among the top collaborators of Samantha Matson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samantha Matson. Samantha Matson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Sarangi, Srikant, Stephen H. Boyle, Cynthia M. Kuhn, et al.. (2021). Sex and race differences of cerebrospinal fluid metabolites in healthy individuals. Metabolomics. 17(2). 13–13. 19 indexed citations
2.
McCallum, Mary, et al.. (2020). Improving health behaviors in patients with peripheral arterial disease – A pilot study of supported self-management. Journal of Vascular Nursing. 39(1). 11–16. 4 indexed citations
3.
Zhu, Hongjie, Mikhail B. Bogdanov, Stephen H. Boyle, et al.. (2013). Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder – Possible Role for Methoxyindole Pathway. PLoS ONE. 8(7). e68283–e68283. 70 indexed citations
4.
Moscovitch‐Lopatin, Miriam, Shirley Eberly, H. Diana Rosas, et al.. (2013). HTRF analysis of soluble huntingtin in PHAROS PBMCs. Neurology. 81(13). 1134–1140. 8 indexed citations
5.
Thomas, Beena, Samantha Matson, Vanita Chopra, et al.. (2013). A novel method for detecting 7-methyl guanine reveals aberrant methylation levels in Huntington disease. Analytical Biochemistry. 436(2). 112–120. 47 indexed citations
6.
Kaddurah‐Daouk, Rima, Wayne R. Matson, Swati Sharma, et al.. (2011). Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept. Translational Psychiatry. 1(7). e26–e26. 102 indexed citations
7.
Kim, Jinho, Daniel J. Amante, Jennifer P. Moody, et al.. (2010). Reduced creatine kinase as a central and peripheral biomarker in Huntington's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802(7-8). 673–681. 41 indexed citations
8.
Stack, Edward C., Jin-Ho Kim, Steven J. Del Signore, et al.. (2008). Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1782(3). 151–162. 47 indexed citations
9.
Cudkowicz, Merit, Patricia L. Andres, Richard Bedlack, et al.. (2008). Phase 2 study of sodium phenylbutyrate in ALS. Amyotrophic Lateral Sclerosis. 10(2). 99–106. 114 indexed citations
10.
Stack, Edward C., Ruth Luthi‐Carter, Byoung Yul Soh, et al.. (2007). Modulation of nucleosome dynamics in Huntington's disease. Human Molecular Genetics. 16(10). 1164–1175. 102 indexed citations
11.
Smith, Karen, Samantha Matson, Wayne R. Matson, et al.. (2006). Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1762(6). 616–626. 111 indexed citations
12.
Codington, John F., Svein Haavik, Najmosama Nikrui, et al.. (2002). Immunologic quantitation of the carcinoma specific human carcinoma antigen in clinical samples. Cancer. 94(3). 803–813. 9 indexed citations
13.
Dedeoglu, Alpaslan, James K. Kubilus, Thomas M. Jeitner, et al.. (2002). Therapeutic Effects of Cystamine in a Murine Model of Huntington's Disease. Journal of Neuroscience. 22(20). 8942–8950. 265 indexed citations
14.
Codington, John F., et al.. (1993). S15.25 Immunoassays for determining the concentration of a carcinoma-specific antigen in the blood of cancer patients. Glycoconjugate Journal. 10(4). 319–319. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026